<i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients

<i>Achromobacter</i> is an opportunistic pathogen that mainly causes chronic lung infections in cystic fibrosis (CF) patients and is associated with increased mortality. Little is known about <i>Achromobacter</i> spp. in the lung transplant recipient (LTXr) population. We aim...

Full description

Bibliographic Details
Main Authors: Cornelia Geisler Crone, Omid Rezahosseini, Hans Henrik Lawaetz Schultz, Tavs Qvist, Helle Krogh Johansen, Susanne Dam Nielsen, Michael Perch
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/2/181
_version_ 1797477376575143936
author Cornelia Geisler Crone
Omid Rezahosseini
Hans Henrik Lawaetz Schultz
Tavs Qvist
Helle Krogh Johansen
Susanne Dam Nielsen
Michael Perch
author_facet Cornelia Geisler Crone
Omid Rezahosseini
Hans Henrik Lawaetz Schultz
Tavs Qvist
Helle Krogh Johansen
Susanne Dam Nielsen
Michael Perch
author_sort Cornelia Geisler Crone
collection DOAJ
description <i>Achromobacter</i> is an opportunistic pathogen that mainly causes chronic lung infections in cystic fibrosis (CF) patients and is associated with increased mortality. Little is known about <i>Achromobacter</i> spp. in the lung transplant recipient (LTXr) population. We aimed at describing rates of <i>Achromobacter</i> spp. infection in LTXr prior to, in relation to, and after transplantation, as well as all-cause mortality proportion in infected and uninfected LTXr. We included 288 adult LTXr who underwent lung transplantation (LTX) between <span style="font-variant: small-caps;">1</span> January 2010 and 31 December 2019 in Denmark. Bronchoalveolar lavage was performed at regular intervals starting two weeks after transplantation. Positive cultures of <i>Achromobacter</i> spp. were identified in nationwide microbiology registries, and infections were categorized as persistent or transient, according to the proportion of positive cultures. A total of 11 of the 288 LTXr had transient (<i>n</i> = 7) or persistent (<i>n</i> = 4) <i>Achromobacter</i> spp. infection after LTX; CF was the underlying disease in 9 out of 11 LTXr. Three out of the four patients, with persistent infection after LTX, also had persistent infection before LTX. The cumulative incidence of the first episode of infection one year after LTX was 3.8% (95% CI: 1.6–6.0). The incidence rates of transient and persistent infection in the first year after LTX were 27 (12–53) and 15 (5–37) per 1000 person-years of follow-up, respectively. The all-cause mortality proportion one year after LTX was 27% in the <i>Achromobacter</i> spp. infected patients and 12% in the uninfected patients (<i>p</i> = 0.114). <i>Achromobacter</i> spp. mainly affected LTXr with CF as the underlying disease and was rare in non-CF LTXr. Larger studies are needed to assess long-term outcomes of <i>Achromobacter</i> spp. in LTXr.
first_indexed 2024-03-09T21:16:45Z
format Article
id doaj.art-3add99c2a2e5456d9498fbc11e960b18
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T21:16:45Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-3add99c2a2e5456d9498fbc11e960b182023-11-23T21:31:37ZengMDPI AGPathogens2076-08172022-01-0111218110.3390/pathogens11020181<i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant RecipientsCornelia Geisler Crone0Omid Rezahosseini1Hans Henrik Lawaetz Schultz2Tavs Qvist3Helle Krogh Johansen4Susanne Dam Nielsen5Michael Perch6Centre of Excellence for Health, Immunity and Infections (CHIP), Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Cardiology, Section for Lung Transplantation, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, DenmarkDepartment of Cardiology, Section for Lung Transplantation, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark<i>Achromobacter</i> is an opportunistic pathogen that mainly causes chronic lung infections in cystic fibrosis (CF) patients and is associated with increased mortality. Little is known about <i>Achromobacter</i> spp. in the lung transplant recipient (LTXr) population. We aimed at describing rates of <i>Achromobacter</i> spp. infection in LTXr prior to, in relation to, and after transplantation, as well as all-cause mortality proportion in infected and uninfected LTXr. We included 288 adult LTXr who underwent lung transplantation (LTX) between <span style="font-variant: small-caps;">1</span> January 2010 and 31 December 2019 in Denmark. Bronchoalveolar lavage was performed at regular intervals starting two weeks after transplantation. Positive cultures of <i>Achromobacter</i> spp. were identified in nationwide microbiology registries, and infections were categorized as persistent or transient, according to the proportion of positive cultures. A total of 11 of the 288 LTXr had transient (<i>n</i> = 7) or persistent (<i>n</i> = 4) <i>Achromobacter</i> spp. infection after LTX; CF was the underlying disease in 9 out of 11 LTXr. Three out of the four patients, with persistent infection after LTX, also had persistent infection before LTX. The cumulative incidence of the first episode of infection one year after LTX was 3.8% (95% CI: 1.6–6.0). The incidence rates of transient and persistent infection in the first year after LTX were 27 (12–53) and 15 (5–37) per 1000 person-years of follow-up, respectively. The all-cause mortality proportion one year after LTX was 27% in the <i>Achromobacter</i> spp. infected patients and 12% in the uninfected patients (<i>p</i> = 0.114). <i>Achromobacter</i> spp. mainly affected LTXr with CF as the underlying disease and was rare in non-CF LTXr. Larger studies are needed to assess long-term outcomes of <i>Achromobacter</i> spp. in LTXr.https://www.mdpi.com/2076-0817/11/2/181<i>Achromobacter</i>lung transplantationsolid organ transplantationcystic fibrosisincidencemortality
spellingShingle Cornelia Geisler Crone
Omid Rezahosseini
Hans Henrik Lawaetz Schultz
Tavs Qvist
Helle Krogh Johansen
Susanne Dam Nielsen
Michael Perch
<i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
Pathogens
<i>Achromobacter</i>
lung transplantation
solid organ transplantation
cystic fibrosis
incidence
mortality
title <i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
title_full <i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
title_fullStr <i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
title_full_unstemmed <i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
title_short <i>Achromobacter</i> spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
title_sort i achromobacter i spp in a cohort of non selected pre and post lung transplant recipients
topic <i>Achromobacter</i>
lung transplantation
solid organ transplantation
cystic fibrosis
incidence
mortality
url https://www.mdpi.com/2076-0817/11/2/181
work_keys_str_mv AT corneliageislercrone iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT omidrezahosseini iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT hanshenriklawaetzschultz iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT tavsqvist iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT hellekroghjohansen iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT susannedamnielsen iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients
AT michaelperch iachromobacterisppinacohortofnonselectedpreandpostlungtransplantrecipients